1. Something old, something new, PET in adrenal imaging

   • Milton D. Gross
   • Domenico Rubello

   Editorial 13 March 2008 Pages: 1233 - 1235

2. Consolidation radioimmunotherapy of follicular lymphoma: a step towards cure?

   • Jean-François Chatal
   • Françoise Kraeber-Bodéré
   • Jacques Barbet

   Editorial 11 March 2008 Pages: 1236 - 1239

3. ¹⁸⁸Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases

   • Amal A. El-Mabhouh
   • John R. Mercer

   Original Article 12 February 2008 Pages: 1240 - 1248

   

4. Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electrons

   • M. Jules Mattes
   • David M. Goldenberg

   Original Article 12 February 2008 Pages: 1249 - 1258

   

5. Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(l-lactic acid) microspheres in healthy pigs

   • M. A. D. Vente
   • J. F. W. Nijsen
   • A. D. van het Schip

   Original Article Open access 11 March 2008 Pages: 1259 - 1271

   

6. The potential of ²¹¹Astatine for NIS-mediated radionuclide therapy in prostate cancer

   • Michael J. Willhauck
   • Bibi-Rana Sharif Samani
   • Christine Spitzweg

   Original Article 11 April 2008 Pages: 1272 - 1281

   

7. Determination of tumour hypoxia with [¹⁸F]EF3 in patients with head and neck tumours: a phase I study to assess the tracer pharmacokinetics, biodistribution and metabolism

   • P. Mahy
   • X. Geets
   • V. Grégoire

   Original Article 04 March 2008 Pages: 1282 - 1289

   

8. Could ^99mTc-glucarate be used to evaluate tumour necrosis?

   • Nathalie Perek
   • Odile Sabido
   • Francis Dubois

   Original article 13 March 2008 Pages: 1290 - 1298

   

9. Staging the Axilla with selective sentinel node biopsy in patients with previous excision of non-palpable and palpable breast cancer

   • R. Ruano
   • M. Ramos
   • M. C. Macias

   Original Article 12 February 2008 Pages: 1299 - 1304

10. ¹⁸F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: Is dual time point imaging worth the effort?

    • Ruoh-Fang Yen
    • Ke-Cheng Chen
    • Yung-Chie Lee

    Original Article 19 February 2008 Pages: 1305 - 1315

    

11. Role of [¹⁸F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary results

    • Laura L. Travaini
    • Giuseppe Trifirò
    • Giovanni Paganelli

    Original Article 13 March 2008 Pages: 1316 - 1322

    

12. The use of ¹⁸F-FDG PET/CT in colorectal liver metastases—comparison with CT and liver MRI

    • G. Kong
    • C. Jackson
    • G. J. R. Cook

    Original Article 18 March 2008 Pages: 1323 - 1329

    

13. Is absolute quantification of dopaminergic neurotransmission studies with ¹²³I SPECT ready for clinical use?

    • Habib Zaidi
    • Georges El Fakhri

    Editorial Commentary 04 June 2008 Pages: 1330 - 1333

14. Quantification of dopaminergic neurotransmission SPECT studies with ¹²³I-labelled radioligands. A comparison between different imaging systems and data acquisition protocols using Monte Carlo simulation

    • Cristina Crespo
    • Judith Gallego
    • Domènec Ros

    Original Article 12 March 2008 Pages: 1334 - 1342

    

15. Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [¹²³I]FP-CIT

    • Andrea Varrone
    • Valeria Sansone
    • Marco Salvatore

    Original Article 19 February 2008 Pages: 1343 - 1349

    

16. AMPT-induced monoamine depletion in humans: evaluation of two alternative [¹²³I]IBZM SPECT procedures

    • Erik Boot
    • Jan Booij
    • Thérèse A. van Amelsvoort

    Original Article Open access 19 February 2008 Pages: 1350 - 1356

    

17. Individual cerebral metabolic deficits in Alzheimer’s disease and amnestic mild cognitive impairment: an FDG PET study

    • Angelo Del Sole
    • Francesca Clerici
    • Giovanni Lucignani

    Original Article 17 April 2008 Pages: 1357 - 1366

    

18. The cost effectiveness of ¹²³I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism

    • Koen Van Laere
    • Ludwig Everaert
    • Thierry Vander Borght

    Original Article 02 April 2008 Pages: 1367 - 1376

    

19. ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine

    • Ferid Haddad
    • Ludovic Ferrer
    • Jean-François Chatal

    Review Article 09 May 2008 Pages: 1377 - 1387

    

20. The power of synergy in the mediastinal staging of lung cancer

    • Giovanni Lucignani

    Focus on 09 May 2008 Pages: 1388 - 1391

21. Treatment efficacy of combined biphosphonates and 186Re-HEDP treatment in cancer patients with bone metastases

    • John Koutsikos
    • Anastasia Leondi

    Letter to the editor 26 April 2008 Pages: 1392 - 1393

22. Multimodality treatment in hormone-refractory prostate cancer patients with bone metastases

    • Marnix G. E. H. Lam
    • Bernard A. Zonnenberg

    Letter to the editor Open access 26 April 2008 Pages: 1394 - 1395

    

23. Spent Technetium-99m generator body adapted for sterilization of radioactive preparations

    • A. Mushtaq

    Letter to the Editor 09 May 2008 Pages: 1396 - 1396

    

24. Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective

    • Paolo Zanotti-Fregonara
    • Domenico Rubello
    • Elif Hindié

    Letter to the Editor 10 May 2008 Pages: 1397 - 1399

25. The specific case of radiopharmaceuticals and GMP—activities of the Radiopharmacy Committee

    • C. Decristoforo
    • P. Elsinga
    • The Radiopharmacy Committee of the EANM

    Letter to the Editor 15 May 2008 Pages: 1400 - 1401

26. Diffuse bone marrow uptake of ^99mTc (III) DMSA in Fanconi’s anemia

    • Sandip Basu
    • Ramesh Asopa
    • Surendra H. Moghe

    Image of the month 06 May 2008 Pages: 1402 - 1402

27. ¹⁸F-FDG PET/CT imaging in tendon xanthomatosis

    • Dae-Weung Kim
    • Chang-Guhn Kim
    • Young Cheon Na

    Image of the month 20 May 2008 Pages: 1403 - 1404

    

28. EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy

    • Michael Lassmann
    • Heribert Hänscheid
    • Markus Luster

    Guidelines 20 May 2008 Pages: 1405 - 1412